Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells

ZS Hashemi, MF Moghadam, M Soleimani - In Vitro Cellular & …, 2015 - Springer
Bone marrow transplants (BMTs) are mainly limited by a low number of CD34+ cells. The
transforming growth factor-beta (TGF-β) pathway downregulation is a key factor that …

The role of using different reference population in the prevalence of low BMD in the thalassemia patients

MR Mohajeri-Tehrani, N Darvishian, F Arab… - Journal of Diabetes & …, 2020 - Springer
Purpose Prevalence of osteoporosis reported as high as 50% in thalassemia major patients.
We compared bone density (BMD) of our patients with results of bone densitometry of …

[HTML][HTML] How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients

MR Mohajeri-Tehrani, SA Alemzadeh… - Iranian Journal of …, 2024 - ncbi.nlm.nih.gov
Background: Beta-thalassemia major patients frequently have endocrinopathies. We tried to
determine relation between demographic and transfusion factor and endocrinopathies …

Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients

F Mohseni, MR Mohajeri-Tehrani, B Larijani… - Archives of …, 2014 - Springer
Low BMDs, short stature, hypogonadism, subclinical hypothyroidism, and IFG are found in
3.3, 10, 33, 16.6, 6.6, and 26.6% of 30 pediatric β thalassemia major patients, respectively …

[HTML][HTML] Bone density changes in thalassaemic patients with age and time period

F Mohseni, M Mohajeri-Tehrani, B Larijani, Z Hamidi - HK J Paediatr, 2016 - hkjpaed.org
Purpose: Chronological and longitudinal changes of bone density in patients with secondary
osteoporosis, have been shown helpful in providing a model of calcium and bone …

[PDF][PDF] Comparison of bone mineral density changes in pediatric thalassemic patients with and without hematopoietic stem cell transplant

AA Hamidieh, MR Mohajeri-Tehrani, M Behfar… - Exp Clin …, 2015 - academia.edu
Objectives: Beta thalassemia major is a genetic hemoglobin disorder that affects bone
density. The disease leads to deteriorating bone structure but can be treated with …

Short-term Assessment of HSCT Effects on the HypothalamusPituitary Axis in Pediatric Thalassemic Patients

AA Hamidieh, F Mohseni, M Behfar… - Archives of Iranian …, 2018 - journalaim.com
Background: Beta thalassemia major (BTM) and its treatment by hematopoietic stem cell
transplantation (HSCT) may have deleterious effects on the endocrine systems. We …

Hematopoetik kök hücre nakli (HKHN) yapılan ve yapılmayan talasemi majorlü olgularda endokrinolojik yan etkilerin karşılaştırılması

B Uzunyayla Sayıcı - dspace.ankara.edu.tr
Talasemi majör hastalarında küratif tedavi yöntemi olan HKHN sonrasında gelişen endokrin
komplikasyonların HKHN olmayan hastalarla farklı olup olmadığının değerlendirilmesi …

Hematopoetik Kök Hücre Nakli (HKHN) Yapılan ve Yapılmayan Talasemi Majorlü Olgularda Endokrinolojik Yan Etkilerin Karşılaştırılması

BU Sayıcı - 2019 - search.proquest.com
AMAÇ: Talasemi majör hastalarında küratif tedavi yöntemi olan HKHN sonrasında gelişen
endokrin komplikasyonların HKHN olmayan hastalarla farklı olup olmadığının …

[PDF][PDF] TÜRKİYE CUMHURİYETİ

XIVXVYTT YAZI, DDİL KARIŞMALARI - dspace.ankara.edu.tr
Diller, konuşurları arasındaki sosyal etkileşimin temelini oluşturur. Sosyal etkileşim ise
kişilerin duygusal zekalarına ve dillerindeki değişimlere yön verir. İletişimde ortaya çıkan …